Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Refractory Sarcoidosis
NCT00855205Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Jul 2009
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in sarcoidosis, sponsored by University of Cincinnati. Started Jul 2009; status: completed.
02
Drugs
rituximab
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NCT00855205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855205.